Dave Ricks

Dave Ricks

Up next

Nir Bar Dea

Bridgewater Associates CEO Nir Bar Dea sits down with David Rubenstein for a wide-ranging conversation about the US economy, rising national debt, the dollar and explains how he sees AI reshaping the future of investing. He also reflects on his unconventional path to Wall Street; ...  Show more

Ana Botin

Santander Executive Chair Ana Botin sits down with David Rubenstein to discuss the bank's expansion in the US, including its recent acquisition of Webster Financial, and why she sees lack of economic growth as one of the biggest challenges facing the global economy. She also disc ...  Show more

Recommended Episodes

Eli Lilly CEO Dave Ricks Talks Fighting Obesity, Developing New Drugs
Bloomberg Talks

Eli Lilly CEO Dave Ricks says the company is working on expanding its medicine supply as the global obesity rate increases. Speaking with Bloomberg's Caroline Hyde at the Economic Club of New York, the head of the pharma giant says that they are looking to create an oral tablet i ...  Show more

Eli Lilly CEO: The Weight-Loss Drug Revolution, AI in Pharma, and Innovation
In Good Company with Nicolai Tangen

Nicolai Tangen meets with David Ricks, CEO of Eli Lilly, for a discussion about the pharmaceutical giant's remarkable journey. At the forefront is Eli Lilly's breakthrough work with weight reduction drugs, which are showing promise far beyond their original ...

  Show more

Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
All-In with Chamath, Jason, Sacks & Friedberg

(0:00) Introducing Eli Lilly CEO Dave Ricks

(1:43) How Eli Lilly discovered the GLP-1 impact on weight loss, counterfeit products from China

(7:08) GLP-1 pricing and capital allocation after a breakout pharma product

(12:56) Why Biotech VC has plummeted, " ...

  Show more